Uncategorized

Regeneron Pharmaceuticals to buy 23andMe for $256M — taking control of genetic data of millions – New York Post

Posted on Author Tim Hodges Comments Off on Regeneron Pharmaceuticals to buy 23andMe for $256M — taking control of genetic data of millions – New York Post
  1. Regeneron Pharmaceuticals to buy 23andMe for $256M — taking control of genetic data of millions  New York Post
  2. Struggling DNA testing firm 23andMe to be bought for $256m  BBC
  3. Bankrupt 23andMe to be bought by pharmaceutical company Regeneron for $256 million  USA Today
  4. 23andMe to Be Bought by Biotech Company for $256 Million  The New York Times
  5. Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million  WSJ